| Literature DB >> 25681195 |
Agnieszka Sieczkowska1, Piotr Landowski2, Pawel Zagozdzon3, Barbara Kaminska2, Carlos Lifschitz4.
Abstract
Small bowel bacterial overgrowth (SBBO) was diagnosed in 22.5% of 40 children treated for 3 months with a proton pump inhibitor (PPI). Compared with those without SBBO, children with SBBO had higher frequency of abdominal pain, bloating, eructation, and flatulence. Patients with gastrointestinal symptoms after PPI treatment should be evaluated for SBBO rather than empirically prolonging PPI therapy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25681195 DOI: 10.1016/j.jpeds.2015.01.004
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406